Cited 1 times in
A Pharmacometric Model to Predict Chemotherapy-Induced Myelosuppression and Associated Risk Factors in Non-Small Cell Lung Cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 박경수 | - |
dc.contributor.author | 채동우 | - |
dc.date.accessioned | 2022-07-08T03:23:19Z | - |
dc.date.available | 2022-07-08T03:23:19Z | - |
dc.date.issued | 2022-04 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/188823 | - |
dc.description.abstract | Chemotherapy often induces severe neutropenia due to the myelosuppressive effect. While predictive pharmacokinetic (PK)/pharmacodynamic (PD) models of absolute neutrophil count (ANC) after anticancer drug administrations have been developed, their deployments to routine clinics have been limited due to the unavailability of PK data and sparseness of PD (or ANC) data. Here, we sought to develop a model describing temporal changes of ANC in non-small cell lung cancer patients receiving (i) combined chemotherapy of paclitaxel and cisplatin and (ii) granulocyte colony stimulating factor (G-CSF) treatment when needed, under such limited circumstances. Maturation of myelocytes into blood neutrophils was described by transit compartments with negative feedback. The K-PD model was employed for drug effects with drug concentration unavailable and the constant model for G-CSF effects. The fitted model exhibited reasonable goodness of fit and parameter estimates. Covariate analyses revealed that ANC decreased in those without diabetes mellitus and female patients. Using the final model obtained, an R Shiny web-based application was developed, which can visualize predicted ANC profiles and associated risk of severe neutropenia for a new patient. Our model and application can be used as a supportive tool to identify patients at the risk of grade 4 neutropenia early and suggest dose reduction. | - |
dc.description.statementOfResponsibility | open | - |
dc.language | English | - |
dc.publisher | MDPI | - |
dc.relation.isPartOf | PHARMACEUTICS | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | A Pharmacometric Model to Predict Chemotherapy-Induced Myelosuppression and Associated Risk Factors in Non-Small Cell Lung Cancer | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Pharmacology (약리학교실) | - |
dc.contributor.googleauthor | Kyemyung Park | - |
dc.contributor.googleauthor | Yukyung Kim | - |
dc.contributor.googleauthor | Mijeong Son | - |
dc.contributor.googleauthor | Dongwoo Chae | - |
dc.contributor.googleauthor | Kyungsoo Park | - |
dc.identifier.doi | 10.3390/pharmaceutics14050914 | - |
dc.contributor.localId | A01422 | - |
dc.contributor.localId | A04014 | - |
dc.relation.journalcode | J02504 | - |
dc.identifier.eissn | 1999-4923 | - |
dc.identifier.pmid | 35631500 | - |
dc.subject.keyword | K-PD model | - |
dc.subject.keyword | R Shiny | - |
dc.subject.keyword | chemotherapy | - |
dc.subject.keyword | cisplatin | - |
dc.subject.keyword | myelosuppression | - |
dc.subject.keyword | neutropenia | - |
dc.subject.keyword | non-small cell lung cancer | - |
dc.subject.keyword | paclitaxel | - |
dc.subject.keyword | pharmacokinetic and pharmacodynamic modeling | - |
dc.subject.keyword | transit compartments | - |
dc.contributor.alternativeName | Park, Kyung Soo | - |
dc.contributor.affiliatedAuthor | 박경수 | - |
dc.contributor.affiliatedAuthor | 채동우 | - |
dc.citation.volume | 14 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 914 | - |
dc.identifier.bibliographicCitation | PHARMACEUTICS, Vol.14(5) : 914, 2022-04 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.